RxCentric Reports Sharp Growth in Its Physician User Base -- Internet Marketing Service Provider Now has Over 25K Registered Physicians.
NEW YORK--(BW HealthWire)--March 6, 2001
RxCentric Inc., a leading Internet Marketing Solutions Provider to the pharmaceutical industry, announced today that the rapid expansion of its user base of prescribing physicians has reached the milestone of 25,000 registered users.
By reaching this milestone, RxCentric has amassed a captive audience that is truly representative of the U.S. population of prescribing physicians. RxCentric has enhanced its ability to immediately execute online pharmaceutical marketing campaigns within its network of physicians and then rollout out the campaign nationally with maximum impact.
RxCentric stated the rapid growth of its user base reflects entrenched communities of satisfied physicians and the attractiveness of its recently enhanced services to targeted physicians. RxCentric has added over 5,000 new users since the New Year bringing the number of users to the service to over 25,000.
"RxCentric is clearly the leader in its ability to offer pharmaceutical companies direct access to a growing relationship platform of specialized physician communities in order to extend, through the use of the Internet, the reach of traditional marketing and sales activities," said Richard Findlay, RxCentric's President and Chief Executive Officer. "This growth provides our pharmaceutical partners unprecedented access to a user base of doctors that are representative of the U.S. population of prescribing physicians."
The firm provides physicians customized information in seven targeted medical specialties through its free, physician-only Internet Service Provider, Doctors Net Access (DNA): Allergy, Cardiology, Neurology, Oncology/Hematology, Primary Care, Pulmonary Medicine and Urology.
Through the medical specialty channels, RxCentric gives physicians an online home that delivers rapid access to leading peer reviewed, objective medical information, as well as resources for their personal interests like news, finance, sports and leisure. Physician users can also access RxCentric's leading drug information databases, with information provided by Facts and Comparisons, as well as medically relevant links that have been tested by physicians.
Partnering with pharmaceutical companies, RxCentric also offers physician users access to a variety of pharmaceutical company-sponsored information and services through RxCentric's unique suite of online products, including online detailing and sampling, continuing medical education (CME), online events and more, all within the DNA home environment.
Findlay credits the latest growth of RxCentric's physician relationship platform to its enhancements of the specialty channels and the successful launching of the Primary Care and Urology channels.
"We are delighted with the response by physicians to our DNA service. It serves to underscore RxCentric as a time efficient resource for busy physicians, helping them to stay abreast of the latest clinical development and drug information," said Findlay. "We've designed the RxCentric channels working directly with physicians to put them in control of their professional and personal information needs, all within one environment. As a result, physicians are staying within the RxCentric network much longer, greatly increasing their exposure to pharmaceutical company-sponsored offerings," he added.
RxCentric is a privately held company with locations in New York, Morristown N.J., Philadelphia, Chicago and San Diego.